Bioversys S.A.S.
- Address
- 1 Rue Du Professeur Calmette
Sponsor Overview
Specializations
Antibacterial Research
Bioversys S.A.S. is focused on infectious disease research with an emphasis on treatment options for Acinetobacter baumannii infections, a major concern in hospital-acquired infection settings and antimicrobial resistance.
- Acinetobacter baumannii infection
- Antimicrobial resistance
- Severe bacterial infections
The sponsor’s clinical activity is centered on anti-infective development and the evaluation of therapies relevant to resistant Gram-negative bacterial pathogens.
Healthy Volunteer Pharmacology
Its clinical research includes work in healthy volunteers, supporting investigation of how candidate therapies behave in the body and how they may be used in future anti-bacterial treatment strategies.
- Healthy volunteer studies
- Pharmacokinetics
- Drug interaction assessment
This area reflects an interest in early clinical understanding of systemic antibacterial agents and their compatibility with established antibiotic therapies.
Gram-Negative Pathogen Treatment
The sponsor’s therapeutic interest extends to Gram-negative bacterial infections, particularly difficult-to-treat organisms associated with limited treatment options and clinical complexity.
- Gram-negative bacteria
- Resistant bacterial pathogens
- Complicated infections
Research activity in this field supports development efforts aimed at addressing unmet needs in critical care and serious bacterial infection management.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 1 Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers |  Austria | Not Recruiting |
| Rifabutin plus polymyxin B combination for adult patients with hospital/ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii |  Croatia Greece | Recruiting |
Data & Insights
This sponsor works with 5 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 12 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases2 trials277 other sponsors
- 2.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
12 centres- Address
- P. O. Box 1425, 411 10 Larissa
- Address
- Konstadinoupoleos 49, 546 42 Thessaloniki
- Address
- Nikis 2, 145 61 Kifissia
- Address
- Ulica Mije Kispatica 12, 10000 Zagreb
- Address
- Mirogojska Cesta 8, Zagreb, 10000 Zagreb
- Address
- Kresimirova 42, 51000 Rijeka
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Bioversys S.A.S..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.